Back

Cardiovascular outcomes in acute coronary syndrome patients with cancer: a statewide population-linkage study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology: predicting adverse effects and prognosis Cardio-Oncology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Christopher Yu

Peter Munk Cardiac Centre, Toronto (Canada)

9 More presentations in this session

Presentation thumbnail
Adverse Myocardial and vascular side effects of Immune Checkpoint Inhibitors: a prospective multimodal cardiovascular assessment (AMICI study)
Doctor M. Mirabel (Paris, FR)
Abstract Slides Video
Presentation thumbnail
The CTOX-Score, a clinical risk prediction tool for cardiovascular toxicity secondary to cancer therapies
Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Fibroblast activation in cardio-oncology
Doctor K. Loganath (Southampton, GB)
Abstract Slides Video
Presentation thumbnail
Sodium-glucose co-transporter-2 inhibitors : a potential cardioprotective agent?
Doctor T. Georgopoulou (Heraklion, GR)
Abstract Slides Video
Presentation thumbnail
Disparities in diabetes-related outcomes in prostate cancer patients - role of social determinants of health and race
Doctor A. Guha (Augusta, US)
Abstract Slides Video

Access the full session

Session thumbnail
Cardio-oncology: predicting adverse effects and prognosis

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Impact of cancer history on non-ST-segment elevation myocardial infarction (NSTEMI) prognosis, a propensity-score matching (PSM) analysis
thumbnail
Congress Presentation
Ischemic and bleeding risk after ST-segment elevated myocardial infarction in patients with active cancer
thumbnail
Congress Presentation
Are cancer survivors at greater risk of coronary artery disease?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources